Relative potency of percutaneously absorbed corticosteroids in the suppression of pituitary-adrenal function.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000494:pharmacology*; D000328:Adult; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005446:Fluocinolone Acetonide / Q000008:administration & dosage*; D005478:Flurandrenolone / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009779:Occlusive Dressings; D009824:Ointments; D010912:Pituitary-Adrenal Function Tests; D011239:Prednisolone / Q000008:administration & dosage*; D011565:Psoriasis / Q000188:drug therapy*; D012869:Skin Absorption; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*
D000305:Adrenal Cortex Hormones; D009824:Ointments; D005446:Fluocinolone Acetonide; D005478:Flurandrenolone; D011239:Prednisolone; D014222:Triamcinolone Acetonide